DDrare
Disease
Drug
Target Gene/Pathway
問合せ先
EN
202. スミス・マギニス症候群
Smith-Magenis syndrome
Clinical trials
/
Disease details
臨床試験数
:
10
/
薬物数
:
12
- (
DrugBank
:
5
) /
標的遺伝子数
:
4
-
標的パスウェイ数
:
7
Search
3 trials found
10
50
100
ALL
diseases per page:
Showing 1 to 3 of 3 diseases
Filter by
Reset
No.
TrialID
Date_
enrollment
Date_
registration
Public_title
Scientific_title
Condition
Intervention
Primary_
sponsor
Secondary_
sponsor
Recruitment_
Status
Inclusion_
agemin
Inclusion_
agemax
Inclusion_
gender
Target_
size
Phase
Countries
1
NCT03492970
(
ClinicalTrials.gov
)
March 7, 2018
1/3/2018
Melatonin
in Adults With SMS
Characterization of Behavioral Disorders and 24 H-
melatonin
Level in Adults With Smith Magenis Syndrome
Characterization of Behavioral Disorders and 24 H-
melatonin
Level in Adults With Smith Magenis Syndro ...
Smith Magenis Syndrome
Biological:
Hourly dosing of the nychtemeral secretion of
melatonin
Hôpital le Vinatier
Hospices Civils de Lyon
Completed
18 Years
65 Years
All
10
N/A
France
2
NCT00506259
(
ClinicalTrials.gov
)
July 17, 2007
21/7/2007
Treatment Strategies for Children With Smith-Magenis Syndrome
A Phase One Treatment Trial of the Circadian Sleep Disturbance in Smith-Magenis Syndrome (SMS)
Developmental Delay Disorders;Chromosome Deletion;Mental Retardation;Sleep Disorders, Circadian Rhythm;Self Injurious Behavior
Developmental Delay Disorders;Chromosome Deletion;Mental Retardation;Sleep Disorders, Circadian Rhyt ...
Drug:
dTR
Melatonin
(NIH CC PDS)
;Device:
Phototherapy (Bright Light)
;Drug:
Melatonin
CR
National Human Genome Research Institute (NHGRI)
NULL
Completed
3 Years
45 Years
All
23
Phase 1
United States
3
NCT00691574
(
ClinicalTrials.gov
)
September 1998
30/5/2008
Melatonin
Levels in Smith Magenis Syndrome (SMS)
Melatonin
Levels in Sleep-disordered Smith-Magenis Syndrome: a Pilot Study
Chromosome Disorders
Dietary Supplement:
Melatonin
;Device:
Enviro-light artificial light box
Oregon Health and Science University
NULL
Terminated
3 Years
85 Years
All
5
N/A
United States